Organization | Dong-A University

Dong-A University Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4

Founded: Busan Korea, Republic of (1946)

Organization Overview

First Clinical Trial

2007

NCT01157988

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2023

Timeline

NOW

Now

Alternative names

9F, DongA University Hospital Department of clinical pharmacology, #26, Daechingongwon-ro, seo-gu, busan, 49201, KOREA | Assistant professor and Chariman, Department of dermatology Dong-A University, College of medicine | Department of Dermatology, College of Medicine, Dong-A University | Dong-A National Univ. Hos. | Donga Univ. | Dong-A University | Dong-A University College of Medicine & Dong-A University Medical Center | Dong-A University Hospital | Dong-A University Hospital, Busan, Republic of Korea | Dong-A university hospital of Korea | Dong-A University Hospital of Korea | Onclogy Division, Dong-A University Hospital | Sung Yong Oh | The Dong-A University Hospital

Active Ingredients

Drugs in Phase 4 Trials (21)

acetylsalicylic acid (aspirin) (1 trial)

atorvastatin (lipitor) (2 trials)

carbamazepine (tegretol) (1 trial)

clopidogrel (plavix) (7 trials)

dapagliflozin (farxiga) (1 trial)

entecavir (baraclude) (2 trials)

icosapent ethyl (vascepa) (1 trial)

ingenol mebutate (picato) (1 trial)

lamotrigine (lamictal) (1 trial)

lidocaine (xylocaine) (6 trials)

olive (2 trials)

olmesartan (benicar) (2 trials)

pitavastatin (livalo) (2 trials)

pravastatin (pravachol) (1 trial)

prilocaine (citanest) (6 trials)

tenofovir (viread) (1 trial)

ticagrelor (brilinta) (7 trials)

valproic acid (depakene) (1 trial)

valsartan (diovan) (2 trials)

vitamin d3 (2 trials)

Drugs in Phase 3 Trials (17)

5,7-dihydroxy-3',4',6-trimethoxyflavone (1 trial)

amlodipine (norvasc) (3 trials)

capecitabine (xeloda) (2 trials)

ckd-825 (1 trial)

donepezil (aricept) (1 trial)

epidermal growth factor (2 trials)

fimasartan (kanarb) (2 trials)

fluorouracil (efudex) (3 trials)

gimeracil (2 trials)

hydrochlorothiazide (esidrix) (2 trials)

leucovorin (3 trials)

levamlodipine (Conjupri) (1 trial)

methylprednisolone (medrol) (1 trial)

oteracil (2 trials)

oxaliplatin (eloxatin) (6 trials)

prasugrel (effient) (5 trials)

tegafur (2 trials)

Drugs in Phase 2 Trials (20)

allogeneic plx-pad cells (1 trial)

avelumab (bavencio) (1 trial)

carfilzomib (kyprolis) (1 trial)

cisplatin (platinol) (3 trials)

cyclophosphamide (cytoxan) (1 trial)

dexamethasone (1 trial)

docetaxel (taxotere) (1 trial)

dwp708 (1 trial)

erlotinib (tarceva) (1 trial)

gemcitabine (gemzar) (2 trials)

ibritumomab tiuxetan (Zevalin) (1 trial)

irinotecan (Camptosar) (2 trials)

Otaplimastat (1 trial)

paclitaxel (taxol) (1 trial)

prednisone (meticorten) (1 trial)

rituximab (rituxan) (1 trial)

rivaroxaban (xarelto) (1 trial)

trastuzumab (herceptin) (1 trial)

warfarin (coumadin) (1 trial)

Drugs in Phase 1 Trials (17)

90-yttrium (1 trial)

aluminum (1 trial)

bazedoxifene (Duavee) (1 trial)

calcipotriene (dovonex) (3 trials)

cilostazol (pletal) (1 trial)

dostarlimab (Jemperli) (1 trial)

fenofibrate (fenoglide) (1 trial)

fluticasone (cutivate) (1 trial)

methyl aminolevulinate (metvixia) (7 trials)

omega-3 fatty acids (Omacor) (1 trial)

phenylpropanolamine (Propadrine) (1 trial)

rosuvastatin (crestor) (1 trial)

tadalafil (cialis) (1 trial)

tamsulosin (flomax) (1 trial)

telmisartan (micardis) (2 trials)

Drugs in Other Trials (5)

carvedilol (coreg) (1 trial)

glucose (1 trial)

icodextrin (Extraneal) (1 trial)

nebivolol (bystolic) (1 trial)

rivastigmine (exelon) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Acute Coronary Syndrome (Phase 3)

Alzheimer Disease (Phase 3)

Arterial Occlusive Diseases (Phase 1)

Arthritis (Phase 3)

Arthritis, Juvenile (Phase 3)

Arthritis, Psoriatic (Phase 3)

Atrial Fibrillation (Phase 3)

Biliary Tract Neoplasms (Phase 2)

Bowen's Disease (Phase 1)

Carcinoma (Phase 2)

Carcinoma, Squamous Cell (Phase 2)

Cardiomyopathies (Phase 4)

Cardiomyopathy, Dilated (Phase 4)

Cerebral Infarction (Phase 2)

Cheilitis (Phase 1)

Coronary Artery Disease (Phase 3)

Coronary Disease (Phase 3)

Diabetes Mellitus (Phase 4)

Dyslipidemias (Phase 1)

Edema (Phase 4)

Epilepsy (Phase 4)

Esophageal Squamous Cell Carcinoma (Phase 2)

Essential Hypertension (Phase 3)

Gastritis (Phase 3)

Hemangiosarcoma (Phase 2)

Hepatitis (Phase 4)

Hepatitis A (Phase 4)

Hepatitis B (Phase 4)

Hepatitis B, Chronic (Phase 4)

Hepatitis, Chronic (Phase 4)

Hiccup (Phase 3)

Hyperlipidemias (Phase 4)

Hyperlipoproteinemias (Phase 4)

Hyperplasia (Phase 1)

Hypertension (Phase 3)

Hypertriglyceridemia (Phase 1)

Infarction (Phase 4)

Intermittent Claudication (Phase 2)

Ischemia (Phase 2)

Ischemic Attack, Transient (Phase 2)

Keratosis (Phase 4)

Keratosis, Actinic (Phase 4)

Kidney Diseases (Phase 4)

Lymphoma (Phase 2)

Lymphoma, B-Cell (Phase 2)

Lymphoma, B-Cell, Marginal Zone (Phase 2)

Lymphoma, Large B-Cell, Diffuse (Phase 2)

Macular Edema (Phase 4)

Myocardial Infarction (Phase 4)

Myocardial Ischemia (Phase 3)

Pancreatic Neoplasms (Phase 2)

Peripheral Arterial Disease (Phase 2)

Prostatic Hyperplasia (Phase 1)

Renal Insufficiency, Chronic (Phase 4)

Skin Diseases (Phase 1)

Spondylitis (Phase 3)

Spondylitis, Ankylosing (Phase 3)

ST Elevation Myocardial Infarction (Phase 3)

Stomach Neoplasms (Phase 3)

Stroke (Phase 2)

Syndrome (Phase 3)

Ventricular Remodeling (Phase 4)

Vitamin D Deficiency (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 71
# of Trial APIs: 80